46 results
8-K
EX-99.1
IVVD
Invivyd Inc
22 Nov 21
Adagio Therapeutics Announces Expansion of Management Team and Board of Directors
5:04pm
responsibility at Novartis, including senior leadership roles in legal and compliance at Novartis Pharmaceuticals Corporation, Novartis Consumer Health … administrative roles of increasing responsibility, including vice chair of clinical operations for the Department of Medicine, vice president of medical
8-K
IVVD
Invivyd Inc
1 Mar 22
Departure of Directors or Certain Officers
5:07pm
her responsibilities. Ellie Hershberger, PharmD, the Company’s Chief Development Officer, will assume responsibility for the Company’s clinical
UPLOAD
IVVD
Invivyd Inc
16 Jun 21
Letter from SEC
12:00am
." These
statements may imply an
inappropriate disclaimer of responsibility with respect to the third
party information and
your own
8-K
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
through roles of increasing responsibility in the areas of marketing, sales, medical affairs and operations in Canada, the U.S. and in Switzerland until his
8-K
IVVD
Invivyd Inc
6 Dec 22
Departure of Directors or Certain Officers
4:28pm
industry in 2002 with Novartis as a medical representative. He progressed through roles of increasing responsibility with Novartis in the areas
DRSLTR
xtmjwb
28 Jun 21
Correspondence regarding draft registration statement
12:00am
DRS/A
EX-10.7
3ngsbtm8pnmvfx
13 Jul 21
Draft registration statement (amended)
12:00am
S-1
EX-10.7
bab yr05pb
16 Jul 21
IPO registration
4:56pm
S-1
EX-10.6
fcxn7hl3bcovtwe0so
16 Jul 21
IPO registration
4:56pm
S-1/A
EX-10.4
q3fm72g7 m7
2 Aug 21
IPO registration (amended)
6:20am
DRS/A
EX-10.6
22ujvc3z43cd
13 Jul 21
Draft registration statement (amended)
12:00am
8-K
EX-99.1
zzqbj1te5h3vxf 6t6ro
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm
DRS/A
EX-10.5
ui3lvrkg4j j45
13 Jul 21
Draft registration statement (amended)
12:00am
S-1
EX-10.5
xy5b9rrhlzw1a
16 Jul 21
IPO registration
4:56pm
8-K
EX-10.2
mvtbbb2ervv38 38utj
13 Oct 22
Invivyd Appoints Fred Driscoll as Interim Chief Financial Officer and Announces Resource Reallocation to Maximize Integrated Discovery
4:16pm
PRE 14A
jn5g70uukopm 3fd3fi2
31 Mar 23
Preliminary proxy
4:36pm
DEF 14A
j9n7dd33dusy
10 Apr 23
Definitive proxy
4:07pm